Clinical safety and efficacy of the first-in-class Rho kinase inhibitor for lowering IOP: netarsudil and the fixed-dose combination of netarsudil and latanoprost “The multiple-hit theory on the pathogenesis of primary open-angle glaucoma” has been added to your cart. View cart €15.00 Clinical safety and efficacy of the first-in-class Rho kinase inhibitor for lowering IOP: netarsudil and the fixed-dose combination of netarsudil and latanoprost quantity Add to cart Category: Articles Tag: Volume 3 Description Description Authors: Janet B. Serle, Jake Radell Related products The 810 Nm I.R. Diode Laser in the pivotal paradigm shift from laser photocoagulation to laser photostimulation €15.00 Add to cart Uveoscleral outflow €15.00 Add to cart Molecular differences in segmental regions of the trabecular meshwork €15.00 Add to cart The role of blood flow in glaucoma €15.00 Add to cart